GenMark Diagnostics to Present at the 2017 William Blair Growth Stock Conference
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will
present at the 2017 William Blair Growth Stock Conference in Chicago on Tuesday, June 13, 2017. The presentation will be delivered
by Hany Massarany, President and Chief Executive Officer, and is scheduled for 3:30 p.m. (CT). The presentation
will be made available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient
care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT- 8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with a
compact, easy-to-use workstation and self-contained, disposable test cartridges. GenMark's ePlex®: The True Sample-to-Answer
Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs,
including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.
GenMark Diagnostics, Inc.
Hany Massarany
President, Chief Executive Officer
760-448-4325
View source version on businesswire.com: http://www.businesswire.com/news/home/20170531006495/en/